Filing Details

Accession Number:
0000899243-21-039976
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-12 21:32:07
Reporting Period:
2021-10-07
Accepted Time:
2021-10-12 21:32:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1809519 Goodrx Holdings Inc. GDRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1632311 Bansi Nagji C/O Goodrx Holdings, Inc.
2701 Olympic Boulevard
Santa Monica CA 90404
President, Healthcare No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-10-07 3,600 $6.84 32,766 No 4 M Direct
Class A Common Stock Disposition 2021-10-07 3,600 $45.05 29,166 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (Right to Buy) Disposition 2021-10-07 3,600 $0.00 3,600 $6.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,600 2030-06-15 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024.
  4. The Reporting Person's prior Form 4 filed on September 16, 2021 incorrectly stated that 309,564 shares underlying this option remained after the reported transactions and should have reported 309,584 shares underlying this option after the reported transactions.